US Supreme Court says confidential sales can invoke on-sale bar

22-01-2019

US Supreme Court says confidential sales can invoke on-sale bar

stocknshares / iStockphoto.com

Companies that sell their inventions to third parties under confidential agreements may still end up invalidating their own patents based on the “on-sale” provision, the US Supreme Court said today.


SCOTUS, US, AIA, patent invalidation, Helsinn Healthcare, Teva, generic version, proprietary information, confidential sales

WIPR